Accendra Health Inc. (ACH) PT Raised to $4.50 at UBS

May 12, 2026 8:36 AM

UBS analyst Kevin Caliendo raised the price target on Accendra Health Inc. (NYSE: ACH) to $4.50 (from $3.00) while maintaining a Neutral rating.

No results found